Cite
HARVARD Citation
Maher, T. et al. (2021). Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. European respiratory journal. 57 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maher, T. et al. (2021). Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. European respiratory journal. 57 (2), p. . [Online].